Substantial Body
Weight Reduction
Patients typically lose 10% to 15%+ of their starting body weight by reducing both overall body fat and harmful abdominal (visceral) fat.*

Available
Subcutaneous Injection
Semaglutide is a medication that mimics the action of GLP-1, a naturally occurring hormone involved in appetite regulation, blood sugar control, and digestion. It is a GLP-1 receptor agonist that can help reduce appetite and food intake when used as part of a medically supervised weight management plan.

Self-Injecting Guide
Step-by-step instructions for safe and easy injections.
Temperature Controlled Packaging
Insulated packaging protects your medication during shipping.
Compounded Semaglutide Vial
Multi-dose vial prepared by a licensed U.S. compounding pharmacy.
Sterile Syringes
Individually wrapped syringes for your prescribed doses.
Alcohol Swabs
Clean the vial top and injection site before each dose.
Gauze Pads
Apply gentle pressure to the injection site afterward.
Cold Pack
Keeps your vial cool until you can refrigerate it.
Self-Injecting Guide
Step-by-step instructions for safe and easy injections.
Temperature Controlled Packaging
Insulated packaging protects your medication during shipping.
Compounded Semaglutide Vial
Multi-dose vial prepared by a licensed U.S. compounding pharmacy.
Sterile Syringes
Individually wrapped syringes for your prescribed doses.
Alcohol Swabs
Clean the vial top and injection site before each dose.
Gauze Pads
Apply gentle pressure to the injection site afterward.
Cold Pack
Keeps your vial cool until you can refrigerate it.
Your compounded semaglutide comes in a multi-dose vial and is administered as a subcutaneous injection. Your care team will provide clear instructions on your prescribed dose, syringe use, injection technique, and storage.


Semaglutide has been extensively studied for weight management, blood sugar control, and related metabolic health outcomes. Clinical trials have evaluated its effectiveness, safety, dosing, and long-term use across diverse patient populations.
Research has reported meaningful reductions in body weight and improvements in several cardiometabolic measures when semaglutide is used alongside lifestyle changes. Explore the evidence behind semaglutide through peer-reviewed clinical studies, systematic reviews, and scientific whitepapers.

Patients typically lose 10% to 15%+ of their starting body weight by reducing both overall body fat and harmful abdominal (visceral) fat.*
It acts directly on brain receptors to signal fullness, curbing hunger and reducing cravings for high-calorie foods.
By slowing down stomach emptying, it keeps you feeling fuller for much longer after eating smaller meal portions.
Increases natural insulin production in response to meals and improves insulin sensitivity, lowering HbA1c levels and helping prevent or manage Type 2 diabetes.
Clinical trials show reduced risk of major adverse cardiovascular events (such as stroke or heart attack) by lowering blood pressure and systemic inflammation.
Emerging research indicates benefits in slowing chronic kidney disease progression and reducing liver fat (steatotic liver disease).
*Weight-loss results vary by individual. Clinical trial results are based on specific populations, doses, treatment durations, and lifestyle interventions and may not reflect results with compounded semaglutide.
Starting a GLP-1 medication can come with side effects, especially as your body adjusts to treatment. Most gastrointestinal side effects are more common when starting treatment or increasing the dose. Our care team is here to help you manage common symptoms and answer questions throughout your weight loss journey.
3 simple steps
Getting started should feel simple.
Answer a few questions about your health history, goals, medications, and overall health. It takes about 5 to 15 minutes.

Meet with a licensed provider by video or phone. They’ll review your health information and lab results to determine whether treatment is medically appropriate. If prescribed, fill your prescription at a pharmacy or choose Ongo Weight Loss for medication delivery and ongoing care.

Choose the treatment plan that works for you. If prescribed through Ongo, your medication is shipped in discreet packaging from a licensed U.S. pharmacy with tracking. Your care team provides regular check-ins, answers your questions, and makes treatment adjustments when medically appropriate.

Semaglutide is administered as a subcutaneous injection, typically once weekly. Your healthcare provider will provide your specific dose, injection volume, and instructions.
Semaglutide is generally taken once weekly. Your prescribed dosing schedule may change as your provider adjusts your treatment based on your response and tolerability.
Weight-loss results vary from person to person. Clinical studies have shown that semaglutide can produce significant weight loss when combined with a reduced-calorie diet and increased physical activity. Individual results may differ, and clinical trial results may not reflect outcomes with compounded semaglutide.
Some people notice changes in appetite within the first few weeks, while weight loss generally occurs gradually over time. Your provider may adjust your dose as your body responds to treatment.
Common side effects may include nausea, vomiting, diarrhea, constipation, bloating, and changes in appetite. Side effects may be more noticeable when starting treatment or increasing the dose.
Do not automatically take an additional dose. Follow the missed-dose instructions provided with your prescription or contact your Ongo care team for guidance.
Semaglutide should not be combined with another semaglutide-containing or GLP-1 medication unless specifically directed by your healthcare provider.
Storage requirements can vary by formulation and dispensing pharmacy. Follow the storage instructions provided with your prescription and pharmacy label.
Your prescribed injection volume depends on the concentration of your specific medication. Never determine your dose from syringe markings alone. Follow the dosing instructions provided by your healthcare provider or pharmacy.
If you think you have taken too much or too little semaglutide, contact your healthcare provider or Ongo care team for instructions. Do not take an additional dose unless instructed to do so.
Yes. Compounded semaglutide is available only with a valid prescription from a licensed healthcare provider.
It may. Treatment commonly begins at a lower dose, and your provider may gradually adjust it based on your response, tolerability, and treatment goals.
Yes. Ongo provides ongoing care and support throughout your treatment. Your care team can answer questions about your medication, dosing, and common side effects.
Yes. Your care team will provide instructions for your prescribed dose, injection technique, and storage. You can also use Ongo's injection guide and video for additional guidance.